Data completeness
0/8 — Limited
Drug data last refreshed 3d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ACTIFED W/ CODEINE is an oral syrup combination product containing antihistamine and decongestant components with codeine, a Schedule II opioid. The product is indicated for relief of cough and cold symptoms in patients requiring opioid-level cough suppression. This is a classic small-molecule cold and cough remedy repositioned in a modern regulatory environment.
Pre-Launch
Pre-launch stage suggests active commercial team building and go-to-market strategy development, with potential for field force expansion pending regulatory clearance.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
This pre-launch product offers immediate career opportunities in launch preparation and commercial field operations, but limited long-term growth potential given the mature, opioid-sensitive market environment. Professionals joining this team should expect involvement in go-to-market strategy, regulatory navigation, and field team deployment rather than innovation or expansion roles.
Brand Manager
Worked on ACTIFED W/ CODEINE at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.